Papers on zilebesiran
15 papers9 new in 30 days
Monday, November 9
AHA Scientific Sessions 2026 Abstract
Angiotensinogen-Targeting RNA Interference with Zilebesiran for Hypertension: A Systematic Review and Meta-Analysis of Randomized Trials
Meta-analysis of randomized trialsZilebesiran
Saturday, November 7
AHA Scientific Sessions 2026 Abstract
Hepatic Angiotensinogen-Lowering RNA Therapeutics for Hypertension: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
Meta-analysis of randomized trialsHypertension
Friday, November 6
Thursday, October 29
Monday, October 26
ESC Congress 2026 Abstract
Dose-response and efficacy ceiling of zilebesiran: a bayesian non-linear spline meta-analysis of phase 1 and KARDIA phase 2 trials
Meta-analysis of randomized trialsZilebesiran
ESC Congress 2026 Abstract
Zilebesiran in combination with a diuretic in patients with uncontrolled hypertension: a subgroup analysis from the Phase 2 KARDIA-3 trial
Randomized trial in 270 peopleZilebesiran
ESC Congress 2026 Abstract
Efficacy and safety of zilebesiran for inadequately controlled hypertension: a systematic review and meta-analysis
Meta-analysis of randomized trialsZilebesiran
Friday, October 23
American Journal of Cardiovascular Drugs
Beyond Conventional Antihypertensives: RNA Interference, Endothelin Antagonism, and Aldosterone-Synthase Inhibition in the Current Therapeutic Landscape
ReviewInterventions
Tuesday, July 14
Hypertension Research
Breakthrough drugs in the treatment of hypertension-related disease
ReviewHypertension
Thursday, March 19
Wednesday, March 11
Molecular Therapy Nucleic Acids
Enhanced liver-targeted delivery with ribofuranose-based GalNAc conjugates
Experiments in non-human primatesInterventions
Sunday, March 1
The Egyptian Heart Journal
Zilebesiran: an RNA interference agent-its need and potential to transform hypertension treatment
ReviewZilebesiran
Wednesday, January 28
Current Opinion in Nephrology and Hypertension
New pharmacological therapies for hypertension
ReviewHypertension
Thursday, January 11
International Journal of Molecular Sciences
Molecular Therapies in Cardiovascular Diseases: Small Interfering RNA in Atherosclerosis, Heart Failure, and Hypertension
ReviewAtherosclerosis